Danish drug developer takes E15.2m injection

BioImage has secured E15.2m second round funding from a consortium of investors led by Abingworth Management.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this